The Drug Enforcement Administration (DEA) and National Institute On Drug Abuse (NIDA) say they are in favor of a White House proposal to streamline the process of researching Schedule I drugs like marijuana and certain psychedelics. The agencies testified at a House Energy and Commerce subcommittee hearing on Thursday, expressing support for the Office of … Continue reading DEA Backs White House Plan To Streamline Research On Marijuana, Psychedelics And Other Schedule I Drugs